‘Preventing drug-resistant TB in India’
Madhukar Pai, Professor, McGill University, Montreal, Canada says a trans-formational change in the relationship between the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
’Pharmacists: an untapped potential in TB care and control’
Manjiri Gharat, Vice-President and Chairperson, Indian Pharmaceutical Association-Community Pharmacy Division (IPA CPD) speaks to…
‘Response to TB in India needs bold policies’
Dr Suvanand Sahu, Team Leader for TB-REACH, Stop TB Partnership presents seven points important to address TB and prevent further…
TB diagnosis in India Challenges and opportunities
Dr Sanjay Sarin, Regional Director, Global Health (Central & South Asia Pacific), BD elaborates on the challenges and…
Epidemiology of TB in India
Dr Giridhar R Babu, Associate Professor, Public Health Foundation of India discusses the imminent need for improved diagnostics…
Glenmark confirms patent challenge for its generic version of FINACEA
Is indicated for the topical treatment of inflammatory papules and pustules of mild to moderate rosacea
FDA VS CHEMISTS An Ongoing Battle
Food and Drug Administration (FDA) Maharashtra and chemists across the state have once again locked horns over the issue of…
GACL bags ‘Best Corporate Social Responsibility Practices’ award
YK Shishode, Public Relations Officer, GACL receives the award
XCODE Life Sciences receives ISBA 2013 Promising Venture Award
Award presented in conjunction with the seventh edition of the Annual Incubator Conference on Business Incubation
PD Hinduja National Hospital and Medical Research Centre, Mumbai bags award
Conferred with the first TB Champion Award by Global Health Strategies